ChemoCentryx, Inc.

CCXI · NASDAQ
Analyze with AI
6/30/2022
3/31/2022
12/31/2021
9/30/2021
Operating Activities
Net Income-$32-$39-$41-$22
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$8$9$7$7
Change in WC-$4$36$20-$14
Other Non-Cash$1$1$1$2
Operating Cash Flow-$26$9-$11-$25
Investing Activities
PP&E Inv.-$0-$0-$0-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$35-$91-$61-$47
Inv. Sales/Matur.$64$70$25$94
Other Inv. Act.$0$0$0$0
Investing Cash Flow$28-$21-$37$42
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$7$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$3$4-$0
Financing Cash Flow$2$3$4-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$4-$9-$44$17
Supplemental Information
Beg. Cash$42$51$95$78
End Cash$45$42$51$95
Free Cash Flow-$27$9-$11-$30